Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

DNA in Civil Cases

By Neal Jardine
December 21, 2007

The future of DNA evidence in civil cases is now upon us. DNA evidence is the most powerful forensic tool available to litigants today. During this decade and beyond, gene expression data developed in connection with the mapping of the human genome will provide causation proof in toxic tort cases and workers' compensation claims that epidemiology studies cannot match. Corporations and their insurance carriers are beginning to reap the financial benefits of toxicogenomic science, which tells them at an early stage whether a toxic exposure has caused an injury to a claimant.

Most, if not all, potential jurors are aware of the use of DNA evidence in criminal cases. The television series 'CSI' and the mass-media 'CSI Effect' have created a desire, in fact a need, among jurors to see DNA proof of certain crimes such as rape or murder. Jurors want to hear about the crime scene investigators with high-tech equipment, cameras, rubber gloves and DNA swabs gathering DNA evidence such as blood, semen and saliva samples. Because jurors are becoming ever more comfortable and familiar with scientific evidence in court, DNA proof has become the smoking gun for a prosecutor to obtain a conviction. On the other hand, the lack of DNA evidence can be used by criminal defendants to raise reasonable doubt for acquittal. For instance, the lack of a DNA match was a key factor in showing the exoneration of the three accused Duke University lacrosse players, and DNA evidence has been used for several years to prove the innocence of death row inmates.

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.

Compliance Officers: Recent Regulatory Guidance and Enforcement Actions and Mitigating the Risk of Personal Liability Image

This article explores legal developments over the past year that may impact compliance officer personal liability.